表紙:肺炎の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版
市場調査レポート
商品コード
1109526

肺炎の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版

Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

出版日: | 発行: GlobalData | ページ情報: 英文 836 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
肺炎の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版
出版日: 2022年05月25日
発行: GlobalData
ページ情報: 英文 836 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の肺炎市場について調査分析し、 投資に関する主要なビジネス戦略、時間とコストを削減するのに役立つ臨床試験の実施に適した場所、主要なビジネスチャンスの特定に役立つ世界の臨床試験市場の上位レベル分析、世界の治療薬市場における国別の試験回数および登録傾向、完了した試験と未完了の試験の臨床試験の成功率、世界・地域・国レベルでの適応症の臨床試験の評価等に関する情報を提供しています。

目次

目次

  • 報告ガイダンス
  • GlobalDataの臨床試験の調査範囲
  • 臨床試験:地域別
  • 臨床試験と平均登録者数:国別
  • 臨床試験:G7諸国別-呼吸器系の臨床試験に対する肺炎の割合
  • 臨床試験:G7諸国におけるフェーズ
  • 臨床試験:G7諸国における試験状況別
  • 臨床試験:E7諸国別-呼吸器系の臨床試験に対する肺炎の割合
  • 臨床試験:E7諸国におけるフェーズ別
  • 臨床試験:E7諸国における試験状況別
  • 臨床試験:フェーズ別
  • 進行中試験:フェーズ別
  • 臨床試験:試験状況別
  • 臨床試験:エンドポイントステータス別
  • 一定期間にわたって採用された被験者
  • 臨床試験:スポンサータイプ別
  • 著名なスポンサー
  • 肺炎治療薬の臨床試験に参加している上位企業
  • 著名な薬物
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 情報源
図表

List of Tables

List of Tables

  • Pneumonia Therapeutics, Global, Clinical Trials by Region, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2022*
  • Proportion of Pneumonia to Respiratory Clinical Trials, G7 Countries (%), 2022*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
  • Proportion of Pneumonia to Respiratory Clinical Trials, E7 Countries (%), 2022*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
  • Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

  • Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
  • Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*
  • Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*
  • Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2022*
  • Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*
  • Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2022*
  • Proportion of Pneumonia to Respiratory Clinical Trials, G7 Countries (%), 2022*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
  • Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
  • Proportion of Pneumonia to Respiratory Clinical Trials, E7 Countries (%), 2022*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
  • Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*
  • Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
  • Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
  • Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*
  • GlobalData Methodology
目次
Product Code: GDHC6882CTIDB

GlobalData's clinical trial report, "Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update" provides an overview of Pneumonia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Pneumonia to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pneumonia to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source